A clinically significant anti-HLA-A2 detectable by extended incubation cytotoxicity and flow cytometric techniques but not by a standard NIH lymphocytotoxicity test
Garner, S.F., Petrochilos, J., Brown, C.J., Cavanna, S., Chanarin, I., Navarrete, C.
Do monocyte ADCC assays accurately predict the severity of hemolytic disease of the newborn caused by antibodies to high-frequency antigens?
Garner, S.F., Devenish, A.